Pharmacokinetics and biological availability of erythromycin
- 1 March 1977
- journal article
- Published by Springer Nature in Infection
- Vol. 5 (1) , 14-22
- https://doi.org/10.1007/bf01639131
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Serum Protein Binding of Erythromycincand Erythromycin 2'-Propionate EsterJournal of Pharmaceutical Sciences, 1972
- ERYTHROMYCIN CONCENTRATIONS IN MIDDLE EAR EXUDATESPediatrics, 1971
- Biochemical basis for the selective toxicity of erythromycinBiochemical Pharmacology, 1970
- The intermolecular complex of erythromycin and ribosomeJournal of Molecular Biology, 1969
- Mode of action of macrolidesBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1968
- Clinical pharmacology of the new penicillins: I. The importance of serum protein binding in determining antimicrobial activity and concentration in serumClinical Pharmacology & Therapeutics, 1966
- Demethylation of erythromycins by rabbit tissues in vitroBiochemical Pharmacology, 1965
- Physicochemical Factors Influencing the Absorption of Erythromycin and its EstersCHEMICAL & PHARMACEUTICAL BULLETIN, 1962
- Biopharmaceutics: Absorption AspectsJournal of Pharmaceutical Sciences, 1961
- Enteric Coatings IV**Received August 13, 1959, from the Research Laboratories of The Upjohn Co., Kalamazoo, Mich.Journal of the American Pharmaceutical Association (Scientific ed.), 1960